{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:41:30Z","timestamp":1788234090085,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Structural disruption of gut microbiota is closely related to the occurrence of non-alcoholic fatty liver disease (NAFLD). Previous research has demonstrated that both curcumin (CUR) and metformin (MET) have a therapeutic effect against NAFLD and play a role in modulating the gut microbiota. However, there is a lack of direct comparison between the two medications in terms of the therapeutic efficacy and the regulatory effect on gut microbiota. In this study, we administered either CUR or MET to rats with high-fat diet (HFD)-induced obesity to observe changes in body parameters, biochemical parameters, liver, and ileum pathology and gut microbiota, and used next generation sequencing and multivariate analysis to evaluate the structural changes of gut microbiota in a NAFLD rat model before and after CUR and MET intervention. It was found that both CUR and MET attenuated hepatic ectopic fat deposition, alleviated inflammatory factors, and improved intestinal barrier integrity in HFD-fed rats. More importantly, CUR and MET reduced the <jats:italic>Firmicutes\/Bacteroidetes<\/jats:italic> ratio and reverted the composition of the HFD-disrupted gut microbiota. Both CUR and MET treatments effectively modified the gut microbiome, enriched the abundance of beneficial bacteria and reduced opportunistic pathogens in obese rats. The abundance of <jats:italic>Butyricicoccus<\/jats:italic> was increased while the abundance of <jats:italic>Dorea<\/jats:italic> was decreased in HFD + CUR group. Besides, some beneficial bacteria such as <jats:italic>Prevotella<\/jats:italic> were increased in MET-treated animals. Spearman\u2019s correlation analysis showed that <jats:italic>Helicobacter, Akkermansia, Desulfovibrio, Romboutsia, Corynebacterium, Lactobacillus, Ruminococcaceae_<\/jats:italic>unclassified, <jats:italic>Lachnospiraceae_unclassified<\/jats:italic>, and <jats:italic>Clostridiales_unclassified<\/jats:italic> showed significantly positive correlations with TG, TC, LDL-C, GLU, IL-6, IL-1\u03b2, and TNF-\u03b1, and negative correlations with HDL-C (both <jats:italic>p<\/jats:italic> &amp;lt; 0.05). However, <jats:italic>Prevotella<\/jats:italic> and <jats:italic>Stomatobaculum<\/jats:italic> showed an opposite trend. In summary, CUR and MET showed similar effects in alleviating hepatic steatosis, improving intestinal barrier integrity and modulating gut microbiota in HFD-induced obesity rats, and therefore may prove to be a novel adjunctive therapy for NAFLD.<\/jats:p>","DOI":"10.3389\/fmicb.2020.555293","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T17:25:28Z","timestamp":1610645128000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Ruifang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurui","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s10620-016-4045-1","article-title":"Gut Microbiota of nonalcoholic fatty liver disease.","volume":"61","author":"Abdou","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.4254\/wjh.v7.i12.1679","article-title":"Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease.","volume":"7","author":"Abdul-Hai","year":"2015","journal-title":"World J. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/cs20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease.","volume":"116","author":"Byrne","year":"2009","journal-title":"Clin. Sci."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9734845","article-title":"Phytochemicals that influence gut microbiota as prophylactics and for the treatment of obesity and inflammatory diseases.","volume":"2018","author":"Carrera-Quintanar","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1039\/c7fo01346a","article-title":"Modulation of gut microbiota by mulberry fruit polysaccharide treatment of obese diabetic db\/db mice.","volume":"9","author":"Chen","year":"2018","journal-title":"Food Funct."},{"key":"B7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","article-title":"Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.","volume":"158","author":"Cox","year":"2014","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2672.1991.tb02739.x","article-title":"The control and consequences of bacterial fermentation in the human colon.","volume":"70","author":"Cummings","year":"1991","journal-title":"J. Appl. Bacteriol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1053\/gast.1996.v110.pm8964397","article-title":"Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model.","volume":"110","author":"D\u2019Argenio","year":"1996","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.bbagen.2017.03.017","article-title":"Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats.","volume":"1861","author":"Feng","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.metabol.2017.12.009","article-title":"Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial.","volume":"82","author":"Ferguson","year":"2018","journal-title":"Metabolism"},{"key":"B12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.arteri.2018.03.004","article-title":"Influence of the microbiota and probiotics in obesity.","volume":"30","author":"Fontan\u00e9","year":"2018","journal-title":"Clin. Investig. Arterioscler."},{"key":"B13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/mnfr.200500013","article-title":"Effects of dietary fiber on inflammatory bowel disease.","volume":"49","author":"Galvez","year":"2005","journal-title":"Mol. Nutr. Food Res."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38874-3","article-title":"Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia.","volume":"9","author":"Granado-Serrano","year":"2019","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/md17080455","article-title":"Long-chain bases from sea cucumber alleviate obesity by modulating gut microbiota.","volume":"17","author":"Hu","year":"2019","journal-title":"Mar. Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E201","DOI":"10.1152\/ajpendo.00285.2017","article-title":"Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity.","volume":"314","author":"Jin","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41366-018-0290-z","article-title":"Gut microbiota and overweight in 3-year old children.","volume":"43","author":"Karvonen","year":"2019","journal-title":"Int. J. Obes."},{"key":"B18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD.","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103075","article-title":"Regulatory efficacy of the polyunsaturated fatty acids from microalgae spirulina platensis on lipid metabolism and gut microbiota in high-fat diet rats.","volume":"19","author":"Li","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1021\/acs.jafc.9b00249","article-title":"Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model.","volume":"67","author":"Lin","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu9101124","article-title":"Gut microbiota and nonalcoholic fatty liver disease: insights on mechanisms and therapy.","volume":"9","author":"Ma","year":"2017","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","article-title":"FLASH: fast length adjustment of short reads to improve genome assemblies.","volume":"27","author":"Mago\u010d","year":"2011","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1586\/17474124.2015.1051029","article-title":"Obesity and the microbiome.","volume":"9","author":"Mathur","year":"2015","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112642","article-title":"The role of probiotics in nonalcoholic fatty liver disease: a new insight into therapeutic strategies.","volume":"11","author":"Meroni","year":"2019","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/gut.2010.215665","article-title":"Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models.","volume":"59","author":"Murphy","year":"2010","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020944","article-title":"Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides\/Prevotella in diet-induced obese mice.","volume":"6","author":"Neyrinck","year":"2011","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1017\/s0007114519001508","article-title":"Curcumin attenuates insulin resistance and hepatic lipid accumulation in a rat model of intra-uterine growth restriction through insulin signalling pathway and sterol regulatory element binding proteins.","volume":"122","author":"Niu","year":"2019","journal-title":"Br. J. Nutr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5152\/tjg.2017.17033","article-title":"Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis.","volume":"28","author":"\u00d6zkul","year":"2017","journal-title":"Turk J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes.","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin.","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1136\/gutjnl-2019-319726","article-title":"Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients.","volume":"69","author":"Rodriguez","year":"2020","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: a randomized controlled trial.","volume":"49","author":"Saberi-Karimian","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/aem.01541-9","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH.","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7261619","article-title":"Modulation of the gut microbiota in rats by hugan qingzhi tablets during the treatment of high-fat-diet-induced nonalcoholic fatty liver Disease.","volume":"2018","author":"Tang","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E334","DOI":"10.1152\/ajpendo.00107.2017","article-title":"Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier.","volume":"314","author":"Van Hul","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","article-title":"Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice.","volume":"11","author":"Velazquez","year":"2019","journal-title":"World J. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ismej.2014.177","article-title":"Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula.","volume":"9","author":"Xu","year":"2015","journal-title":"ISME J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49462-w","article-title":"Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities.","volume":"9","author":"Zeng","year":"2019","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109131","article-title":"Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice.","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/srep14405","article-title":"Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2020.555293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T07:52:55Z","timestamp":1611129175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2020.555293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":48,"alternative-id":["10.3389\/fmicb.2020.555293"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.555293","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"article-number":"555293"}}